Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 2 (of 2 Records) |
Query Trace: Pancreatic Neoplasms and SLCO1B1[original query] |
---|
SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1. Pancreas 0 47 (5): 637-642. Sato Yasunori, Ueno Hideki, Ioka Tatsuya, Ohkawa Shinichi, Ikeda Masafumi, Shimamura Tomotaka, Tsuji Akihito, Tsuchiya Yoshiaki, Furuse Junji, Ishii Hiroshi, Furuya Ken, Iguchi Haruo, Saito Yoshihiro, Kaniwa Nahoko, Sawada Jun-Ichi, Sakamoto Hiromi, Sekine Akihiro, Okusaka Takuji, Yoshida Teruhiko, |
Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer. Anticancer research 2024 10 44 (11): 5023-5033. Hana Nakayama, Hiroo Ishida, Masanori Iidaka, Shoko Kato, Kei Nakatani, Akihiro Nakayama, Toshihiro Noguchi, Shigetoshi Nishihara, Shu Oikawa, Tomono Usami, Yuta Mitsui, Y U Ishii, Hirokazu Toshima, Kouji Kobayashi, Remi Murase, Natsumi Matsumoto, Kosuke Suzuki, Ken Shimada, Hitoshi Yoshida, Ken-Ichi Fuji |
- Page last reviewed:Feb 1, 2024
- Content source: